Natasha Strydom

Also affiliated with University of California, San Francisco

MedicineComputer ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis”.

Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00506-21

N/A

0.533DataRank · unranked

34 citations

Jansy P. Sarathy, Ning Wang, Firat Kaya, Matthew Zimmerman, Natasha Strydom +9 more

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01727-19

N/A

0.529DataRank · unranked

33 citations

Natasha Strydom, Sandeep Tyagi, Heena Soni, Rokeya Tasneen, Eric L. Nuermberger +2 more

Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis

PLoS Computational Biology(2020)10.1371/journal.pcbi.1008107

N/A

0.505DataRank · unranked

28 citations

Natasha Strydom, William S. Fox, Ron J. Keizer, Radojka M. Savić, John Fors

Drug concentration at the site of disease in children with pulmonary tuberculosis

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac103

N/A

0.292DataRank · unranked

6 citations

Ahmed A. Abulfathi, Natasha Strydom, Pierre Goussard, Abraham C. van Wyk, Anne Marie Demers +16 more

Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data

iScience(2025)10.1016/j.isci.2025.111932

N/A

0.241DataRank · unranked

4 citations

Anu Patel, Bernard Ngara, Rob C. van Wijk, Natasha Strydom, Qianwen Wang +9 more

Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis

The Annual Review of Pharmacology and Toxicology(2020)10.1146/annurev-pharmtox-030920-011143

N/A

0DataRank · unranked

48 citations

Natasha Strydom, Qianwen Wang, Nan Zhang, Eric L. Nuermberger, Véronique Dartois +2 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

European Respiratory Journal(2023)10.1183/13993003.00165-2023

N/A

0DataRank · unranked

16 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.18.524608

N/A

0DataRank · unranked

2 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

Lesion penetration predicts tuberculosis regimen success: a validated translational tool for de-risking late-stage drug development

Research Square(2025)10.21203/rs.3.rs-6890010/v1

N/A

0DataRank · unranked

0 citations

Jacqueline P. Ernest, Annamarie E. Bustion, Anu Patel, Jansy P. Sarathy, Firat Kaya +9 more